In preparation for entry in to the Canadian pharmaceutical market Hedley Technologies Inc. ("Hedley")(TSX VENTURE:HED), has incorporated a new 100% owned subsidiary, BioSyent Pharma Inc. ("BioSyent Pharma"). BioSyent Pharma is the commercial entity for Hedley's pharmaceutical operations and will be engaged in sourcing, managing the regulatory approval process, marketing, and distribution of proven safe and effective pharmaceutical products.